Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biomarkers of Fibrosis in Patients with COVID-19 One Year After Hospital Discharge: A Prospective Cohort Study.
Mulet A, Tarrasó J, Rodríguez-Borja E, Carbonell-Asins JA, Lope-Martínez A, Martí-Martinez A, Murria R, Safont B, Fernandez-Fabrellas E, Ros JA, Rodriguez-Portal JA, Andreu AL, Soriano JB, Signes-Costa J. Mulet A, et al. Among authors: ros ja. Am J Respir Cell Mol Biol. 2023 Sep;69(3):321-327. doi: 10.1165/rcmb.2022-0474OC. Am J Respir Cell Mol Biol. 2023. PMID: 36848314 Free PMC article.
The effect of post-discharge educational intervention on patients in achieving objectives in modifiable risk factors six months after discharge following an episode of acute coronary syndrome, (CAM-2 Project): a randomized controlled trial.
Muñiz J, Gómez-Doblas JJ, Santiago-Pérez MI, Lekuona-Goya I, Murga-Eizagaetxebarría N, de Teresa-Galván SS E, Cruz-Fernández JM, Castro-Beiras A; CAM2 Project working group. Muñiz J, et al. Health Qual Life Outcomes. 2010 Nov 22;8:137. doi: 10.1186/1477-7525-8-137. Health Qual Life Outcomes. 2010. PMID: 21092191 Free PMC article. Clinical Trial.
Lung function and radiological findings 1 year after COVID-19: a prospective follow-up.
Tarraso J, Safont B, Carbonell-Asins JA, Fernandez-Fabrellas E, Sancho-Chust JN, Naval E, Amat B, Herrera S, Ros JA, Soler-Cataluña JJ, Rodriguez-Portal JA, Andreu AL, Marín M, Rodriguez-Hermosa JL, Gonzalez-Villaescusa C, Soriano JB, Signes-Costa J; COVID-FIBROTIC study team. Tarraso J, et al. Among authors: ros ja. Respir Res. 2022 Sep 12;23(1):242. doi: 10.1186/s12931-022-02166-8. Respir Res. 2022. PMID: 36096801 Free PMC article.
Lung Function, Radiological Findings and Biomarkers of Fibrogenesis in a Cohort of COVID-19 Patients Six Months After Hospital Discharge.
Safont B, Tarraso J, Rodriguez-Borja E, Fernández-Fabrellas E, Sancho-Chust JN, Molina V, Lopez-Ramirez C, Lope-Martinez A, Cabanes L, Andreu AL, Herrera S, Lahosa C, Ros JA, Rodriguez-Hermosa JL, Soriano JB, Moret-Tatay I, Carbonell-Asins JA, Mulet A, Signes-Costa J. Safont B, et al. Among authors: ros ja. Arch Bronconeumol. 2022 Feb;58(2):142-149. doi: 10.1016/j.arbres.2021.08.014. Epub 2021 Sep 3. Arch Bronconeumol. 2022. PMID: 34497426 Free PMC article.
Risk Factors of Poor Outcomes after Admission for a COPD Exacerbation: Multivariate Logistic Predictive Models.
García-Rivero JL, Esquinas C, Barrecheguren M, Bonnin-Vilaplana M, García-Sidro P, Herrejón A, Martinez-Rivera C, Malo de Molina R, Marcos PJ, Mayoralas S, Naval E, Ros JA, Valle M, Miravitlles M. García-Rivero JL, et al. Among authors: ros ja. COPD. 2017 Apr;14(2):164-169. doi: 10.1080/15412555.2016.1260538. Epub 2016 Dec 16. COPD. 2017. PMID: 27983876
The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations.
García-Sidro P, Naval E, Martinez Rivera C, Bonnin-Vilaplana M, Garcia-Rivero JL, Herrejón A, Malo de Molina R, Marcos PJ, Mayoralas-Alises S, Ros JA, Valle M, Esquinas C, Barrecheguren M, Miravitlles M. García-Sidro P, et al. Among authors: ros ja. Respir Med. 2015 Dec;109(12):1546-52. doi: 10.1016/j.rmed.2015.10.011. Epub 2015 Oct 27. Respir Med. 2015. PMID: 26542727 Free article.
What pulmonologists think about the asthma-COPD overlap syndrome.
Miravitlles M, Alcázar B, Alvarez FJ, Bazús T, Calle M, Casanova C, Cisneros C, de-Torres JP, Entrenas LM, Esteban C, García-Sidro P, Cosio BG, Huerta A, Iriberri M, Izquierdo JL, López-Viña A, López-Campos JL, Martínez-Moragón E, Pérez de Llano L, Perpiñá M, Ros JA, Serrano J, Soler-Cataluña JJ, Torrego A, Urrutia I, Plaza V. Miravitlles M, et al. Among authors: ros ja. Int J Chron Obstruct Pulmon Dis. 2015 Jul 15;10:1321-30. doi: 10.2147/COPD.S88667. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26270415 Free PMC article.
Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.
Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Rydén L, Neal B, Malmberg K, Wedel H, Buse JB, Henry RR, Weichert A, Cannata R, Svensson A, Volz D, Grobbee DE; AleCardio Investigators. Lincoff AM, et al. JAMA. 2014 Apr 16;311(15):1515-25. doi: 10.1001/jama.2014.3321. JAMA. 2014. PMID: 24682069 Clinical Trial.
Lifestyle interventions for diabetes mellitus type 2 prevention.
Sagarra R, Costa B, Cabré JJ, Solà-Morales O, Barrio F; el Grupo de Investigación DE-PLAN-CAT/PREDICE. Sagarra R, et al. Rev Clin Esp (Barc). 2014 Mar;214(2):59-68. doi: 10.1016/j.rce.2013.10.005. Epub 2013 Nov 20. Rev Clin Esp (Barc). 2014. PMID: 24267869 English, Spanish.
Factors associated with hospital admission for exacerbation of chronic obstructive pulmonary disease.
Alcázar B, García-Polo C, Herrejón A, Ruiz LA, de Miguel J, Ros JA, García-Sidro P, Conde GT, López-Campos JL, Martínez C, Costán J, Bonnin M, Mayoralas S, Miravitlles M. Alcázar B, et al. Among authors: ros ja. Arch Bronconeumol. 2012 Mar;48(3):70-6. doi: 10.1016/j.arbres.2011.10.009. Epub 2011 Dec 21. Arch Bronconeumol. 2012. PMID: 22196478 English, Spanish.
15 results